Fabiana del Luján Alovero is an Argentine researcher and professor who trained in Chemical Sciences and Microbiology at the National University of Córdoba, Argentina.
Alovero conducts research in the field of medical sciences, particularly in areas related to biotechnology, antimicrobial resistance, and microbiology.
In her studies, the Argentine researcher applies health and therapeutic technologies to connect these with medications and non-endemic diseases. Alovero contributes to the understanding of antimicrobials and their relationship with antimicrobial therapy and resistant microorganisms.
Alovero and her connection to science
Alovero works in the field of microbiology, the discipline responsible for the study of microorganisms—organisms invisible to the human eye. These are commonly referred to as microbes, and they are studied using microscopes.
This discipline is part of the biological sciences and includes the study of organisms such as bacteria, fungi, and agents like viruses, among others.
Alovero is affiliated with various academic and scientific institutions, including the National Scientific and Technical Research Council (CONICET), an Argentine body dedicated to research in science and technology.
She also works at the Scientific and Technological Center of Córdoba (CCT) and the Research and Development Unit in Pharmaceutical Technology (UNITEFA).
The latter is part of the Department of Pharmaceutical Sciences at the Faculty of Chemical Sciences, within the university where Alovero completed her academic training.
Meanwhile, the CCT represents CONICET in Córdoba and oversees various scientific and technological institutions conducting research in chemistry and other sciences.
Alovero’s specialty: antimicrobials
Alovero’s main field of expertise is antimicrobials, which are agents that kill or inhibit the growth of microbes. These agents are commonly referred to as antimicrobial drugs due to their action against microorganisms.
Antimicrobials, such as antibiotics (used to treat bacterial infections), are essential in fighting infections.
In her research, Alovero explores the systems that deliver antimicrobial agents, as well as the existence and understanding of antimicrobial therapies aimed at tackling resistant microorganisms.
Combating antimicrobial resistance
Antimicrobial resistance is currently one of the key issues addressed by health-related institutions and global health agendas.
It refers to the ability of microorganisms to resist the effects of antibiotics intended to eliminate them. This ability allows these microbes to survive and even become immune to medication.
Among the studies addressing this resistance, Alovero and her team are investigating more effective antibiotic delivery systems.
The Argentine researcher, along with her team, aims to design antimicrobial delivery systems that combine antibiotics with polymers. Through laboratory testing, the study demonstrated that this combination improves the efficacy of the drug, thus enhancing its action against antimicrobial resistance.
In their experiments, the research team applied this antibiotic-polymer combination to combat Pseudomonas aeruginosa, a critical and resistant bacterium.
The combination successfully eradicated this superbug.
A global health concern
The World Health Organization (WHO) has described antimicrobial resistance as one of the major threats to public health.
It is responsible for millions of deaths annually, and a growing number of studies aim to develop effective drugs and medications to address this issue.
One of the main causes of antimicrobial resistance is the misuse and uncontrolled consumption of antibiotics.
To tackle this, regulations and policies are being proposed to ensure the appropriate use and purchase of medications, thereby preventing further development of resistance.
Numerous studies are being conducted to explore different methods, applications, and lab tests in search of new techniques and pathways to combat antimicrobial resistance.
Among the scientific figures in Argentina dedicated to this topic is Fabiana Alovero.
The Argentine researcher investigates methods to fight resistance, aiming to enhance the effectiveness of antibiotics and reduce the power of harmful microorganisms.
By applying microbiology, biotechnology, and chemical sciences, Alovero and her team strive to contribute to the field of medical and biological sciences.
Additionally, Alovero has addressed other issues in her research, such as the proper use of disinfectants and antiseptics during the COVID-19 pandemic.
